Luke Swank, | |
476 E Midvalley Rd, Enoch, UT 84721-7603 | |
(435) 263-0355 | |
(435) 263-0123 |
Full Name | Luke Swank |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Location | 476 E Midvalley Rd, Enoch, Utah |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225432669 | NPI | - | NPPES |
1114875 | Other | GA | NCCPA NUMBER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Luke Swank, 476 E Midvalley Rd, Enoch, UT 84721-7603 Ph: (435) 263-0355 | Luke Swank, 476 E Midvalley Rd, Enoch, UT 84721-7603 Ph: (435) 263-0355 |
News Archive
Scientists say they are a step closer to developing a drug to kill the trypanosome parasite that causes human African trypanosomiasis, otherwise known as sleeping sickness, paving the way for a potential cure.
Computer-based modeling is helping to further reduce length of hospital stay and duration of treatment with opioids that are used therapeutically to wean babies born in withdrawal from drugs their mothers have taken. This condition is known as neonatal abstinence syndrome (NAS).
A newly-discovered protein found only in prostate cancer cells could be used as a marker of the disease and offer a new treatment target, according to a study in the British Journal of Cancer.
The American Academy of Neurology (AAN) is awarding the 2010 Sheila Essey Award-An Award for ALS Research to Clive Svendsen, PhD, with the Cedars-Sinai Regenerative Medicine Institute in Los Angeles, CA. Svendsen will receive the award during the AAN's 62nd Annual Meeting in Toronto, held April 10 through April 17, 2010.
› Verified 1 days ago